Claus Bolte has taken on the newly created role of Chief Medical Officer at Swissmedic effective 1 July 2023. He will primarily develop clinical and regulatory scientific issues at a strategic level.
13.07.2023
Claus Bolte was Head of the Authorisation Sector at Swissmedic for eight years until June 2023. Since the start of July, he has taken on the newly created role of Chief Medical Officer. He will work on clinical and regulatory scientific issues at a strategic level and follow up relevant developments at national and international level on behalf of the Executive Director and the Management Board. The role will initially be for a temporary period of two years.
Elisabeth Klenke, previously his deputy, is Head of the Authorisation Sector ad interim. Dr Bolte will remain available to her as a contact during the transition phase, but will not perform any operational tasks. The role of Head of the Authorisation Sector has been advertised.
Executive Director of Swissmedic Raimund Bruhin is pleased that Claus Bolte will continue to work for the Swiss Agency for Therapeutic Products. “His longstanding and international experience and proven skills will help ensure business continuity and performance at Swissmedic. In parallel, the new role is enabling an innovative model to be tested.”